Patent · US Active

Gene expression profile algorithm and test for determining prognosis of prostate cancer

US8725426B2 · kind B2 · utility

10Cited by

7References

22Claims

0Family size

Assignee

Genomic Health, Inc. · US

Inventors

Steve Shak · Hillsborough, US
Mark Lee · Burbank, US
William Novotny · Foster City, US
Tara Maddala · Sunnyvale, US
Michael Crager · Menlo Park, US
Diana Cherbavaz · San Francisco, US
Robert J. Pelham · Belmont, US
Carl L. Millward · Burlingame, US
Dejan Knezevic · Palo Alto, US

Key dates

Filing date	Jan 28, 2013
Grant date	May 13, 2014
Priority date	—
Expiry date	Jan 28, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldComputer technology
WIPO sectorElectrical engineering

Abstract

The present invention provides algorithm-based molecular assays that involve measurement of expression levels of genes, or their co-expressed genes, from a biological sample obtained from a prostate cancer patient. The genes may be grouped into functional gene subsets for calculating a quantitative score useful to predict a likelihood of a clinical outcome for a prostate cancer patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.